Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harnessing the Beneficial Non-specific Effects of Measles-mumps-rubella Vaccine in Children on Infection With Unrelated Pathogens and Allergic Diseases - a Single-centre Phase IV RCT With a Factorial Design

NCT05758532 is registered in ClinicalTrials.gov with Laure Pittet, MD-PhD as lead sponsor.

NCT NCT05758532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harnessing the Beneficial Non-specific Effects of Measles-mumps-rubella Vaccine in Children on Infection With Unrelated Pathogens and Allergic Diseases - a Single-centre Phase IV RCT With a Factorial Design
Lead sponsor
Laure Pittet, MD-PhD
Phase
Phase 4
Overall status
Recruiting
Start date
March 17, 2023
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, eczema, infections, respiratory tract infections